---
layout: minimal-medicine
title: Ximelagatran
---

# Ximelagatran
### Generic Name
Ximelagatran

### Usage
Ximelagatran was an investigational oral anticoagulant intended to prevent blood clots.  Its primary use was to be an alternative to warfarin, offering a potentially more convenient and safer option for preventing stroke and other thromboembolic events (blood clots that travel and block blood vessels).  However, due to safety concerns (see below), ximelagatran was withdrawn from the market and is no longer available.


### Dosage
Since ximelagatran is no longer available, dosage information is for historical reference only and should not be used to self-medicate.  Dosage regimens varied depending on the indication and patient characteristics, and would have been determined by a physician.  The drug was typically administered orally.


### Side Effects
Because ximelagatran is no longer available, this information is for historical reference only.  The most significant side effect that led to the withdrawal of ximelagatran was:

* **Hepatotoxicity (liver damage):**  This was a serious adverse effect observed in clinical trials.

Other reported side effects, though less frequent than hepatotoxicity, included:

* Bleeding (ranging from minor bruising to more serious events)
* Nausea
* Diarrhea
* Abdominal pain
* Headache


**Important Note:** This list is not exhaustive.  If you experienced any adverse effects while taking ximelagatran (in the past), it is crucial to consult a healthcare provider.


### How it Works
Ximelagatran is a prodrug, meaning it's converted into its active form, melagatran, in the body. Melagatran is a direct thrombin inhibitor. Thrombin is a crucial enzyme in the blood clotting cascade.  By directly inhibiting thrombin, melagatran prevents the formation of blood clots, thus reducing the risk of thromboembolic events.


### Precautions
**Because ximelagatran is no longer available, these precautions are for historical context only and are not applicable to current medical practice.**  Significant concerns regarding hepatotoxicity were identified.  Other potential precautions would have likely included interactions with other medications that affect liver function or blood clotting.  As with all anticoagulants, careful monitoring and close physician supervision would have been necessary.  Use during pregnancy and breastfeeding would have required careful consideration.


### FAQs
**Q: Is ximelagatran still available?**

A: No, ximelagatran was withdrawn from the market due to safety concerns, primarily the risk of liver damage.

**Q: What are the alternatives to ximelagatran?**

A:  Several other anticoagulants are currently available, including warfarin, apixaban, rivaroxaban, dabigatran, and edoxaban. A physician can determine the most suitable option based on individual health needs and circumstances.

**Q:  What should I do if I have any leftover ximelagatran?**

A:  Because it's no longer on the market, any remaining medication should be disposed of properly according to your local regulations or your pharmacist's guidance.  Do not attempt to use it.

**Q:  If I previously experienced side effects from ximelagatran, what should I do?**

A:  It is essential to inform your physician about any previous adverse reactions to any medication, including ximelagatran.  This information will be vital in helping your doctor select the most appropriate treatment for you in the future.

**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult a healthcare professional for any health concerns or before making any decisions related to your health or treatment.
